Pretreatment Factors Associated with Recurrence for Patients with Cervical Cancer International Federation of Gynecology and Obstetrics Stage IB1 Disease

Publisher： Karger

E-ISSN： 1423-002x|81|4|339-345

ISSN： 0378-7346

Source： Gynecologic and Obstetric Investigation, Vol.81, Iss.4, 2015-11, pp. : 339-345

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nonattendance in Obstetrics and Gynecology Patients

By  

Gynecologic and Obstetric Investigation, Vol. 66, Iss. 1, 2008-02 ,pp. : 40-43

Karger

Access to resources Recommend Favorite

Prognostic Significance of Pretreatment Plasma Fibrinogen and Platelet Levels in Patients with Early-Stage Cervical Cancer

By  

Gynecologic and Obstetric Investigation, Vol. 79, Iss. 1, 2014-09 ,pp. : 25-33

Karger

Access to resources Recommend Favorite

Treatment Patterns and Outcomes in Bulky Stage IB2 Cervical Cancer Patients: A Single Institution’s Experience over 14 Years

By  

Gynecologic and Obstetric Investigation, Vol. 71, Iss. 1, 2010-12 ,pp. : 19-23

Karger

Access to resources Recommend Favorite

Prognostic Value of p53 Expression in Stage IB1 Cervical Carcinoma

By  

Gynecologic and Obstetric Investigation, Vol. 49, Iss. 4, 2000-05 ,pp. : 266-271

Karger

Access to resources Recommend Favorite

Recurrence and Survival Analyses of 1,115 Cervical Cancer Patients Treated with Radical Hysterectomy

By  

Gynecologic and Obstetric Investigation, Vol. 47, Iss. 2, 1999-02 ,pp. : 127-132

Karger

Access to resources Recommend Favorite